FindTrial
Sign In

Effect of nalbuphine versus fentanyl as an adjuvant in epidural anesthesia

Analgesic Effect Of Nalbuphine Versus Fentanyl Citrate As An Adjuvant To 0.5% Bupivacaine In Epidural Anesthesia In Patients Undergoing Urological Surgeries: A Randomized Double Blind Interventional study in SMS Medical College And Attached Group Of Hospitals during 2020-2021

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036643
Enrollment
90
Registered
2021-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: nalbuphine 10mg: 1ml of nalbuphine(10mg) added to 15 ml of 0.5% isobaric bupivacaine total 16 ml given epidurally once Control Intervention2: Fentanyl 50 microgram: 15 ml of 0.5

Sponsors

SMS medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consent for participation in study 2. Patients posted for urological surgeries belonging to ASA grade 1 and 2 3. Weigh 45 to 70 kg

Exclusion criteria

Exclusion criteria: 1.Obese patients , uncontrollable hypertension, uncontrollable diabetes mellitus ,severe CVS malformation,renal or hepatic failure , with the history of neurological surgeries 2 . H/o spinal surgery , spinal deformity or infection at local site 3 . Coagulation defects those on anticoagulants 4 . Allergic to any of concerned drugs

Design outcomes

Primary

MeasureTime frame
time duration after which first rescue analgesia requiredTimepoint: After surgery when VAS score is 4 or more—

Secondary

MeasureTime frame
To determine the mean VAS score for first 6 hour , 6 to 12 and 12 to 24 hours. 2.To determine the percentage of cases who develop side effect( if any ) in both the groups.Timepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Veena m

SMS Medical college

vkothari66@gmail.com9828020186

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026